Stocks
Krystal Biotech, Inc.KRYS
NASDAQHealthcareBiotechnology$247.26-1.61%
Develops gene therapies for rare dermatological diseases using a proprietary HSV-1–based delivery platform designed for repeat dosing directly to the skin. Its lead product, Vyjuvek, is approved for the treatment of dystrophic epidermolysis bullosa, providing the company with its first commercial re...
Market Cap: $7.2B52W Range: $122.80 – $298.30
Congressional Interest in Krystal Biotech, Inc. (KRYS)
1 member of Congress has disclosed 1 trade in Krystal Biotech, Inc. (KRYS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading KRYS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-12-12 | Christopher L. Jacobs | buy | $1K – $15K |